Skip to main content

How Regeneron Relies on Alation for Fast and FAIR Data Access to Drive Innovation

Published Date

In 2020, Regeneron became a household name when its COVID-19 antibody cocktail, REGEN-COV, proved to be a game-changer in the treatment of the virus. Regeneron's mission is to transform healthcare by speeding the development of treatments, and this became its crowning achievement. 

Because when you’re racing against the clock to create new medicines, every minute counts. Scientists need research data at their fingertips. Today, Regeneron uses Alation to make their data Findable, Accessible, Interoperable, and Reusable, based on the principles of the FAIR Initiative. 

Patrick Saucier, Director of Data Strategy & Governance at Regeneron joins Alation’s Matt Turner, Director of Industry Strategy, for a fireside chat. Patrick discusses his experience using Alation to accelerate Regeneron’s transformation into a data-driven organization and shares details about his unique implementation. 

Watch this Data Dialog to learn how Regeneron:

  1. Helps researchers find data quickly with a centralized metadata repository in Alation
  2. Governs their data through data stewardship, clear policies, and Trust Flags
  3. Uses Alation to bring new medicines to market faster through its FAIR initiative principles